RK
Ramesh Khurana
About Ramesh Khurana
Ramesh Khurana has 24 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Gnosis Pharmaceuticals Private Limited and Tycoon Pharmaceuticals Private Limited. Formerly with 1 company, such as Stalwart Lifesciences Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Gnosis Pharmaceuticals Private Limited
U24231DL2005PTC134162
|
Director | 26 Nov 2011 | 2005 | Active |
Tycoon Pharmaceuticals Private Limited
U24239DL2002PTC115809
|
Director | 13 Jun 2002 | 2002 | Active |
Wellchem Healthcare Llp
AAI-7728
|
Designated Partner | 08 Mar 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Stalwart Lifesciences Private Limited
U85100CH2011PTC032879
|
Director | 29 Jun 2013 | 2011 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Khurana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Khurana
Ramesh Khurana has 24 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Gnosis Pharmaceuticals Private Limited and Tycoon Pharmaceuticals Private Limited. Formerly with 1 company, such as Stalwart Lifesciences Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Ramesh Khurana is associated with 3 companies as Director and Designated Partner.
Ramesh Khurana has expertise in General Business, Healthcare.
Ramesh Khurana has 24 years in corporate governance.